Recruiting

Letrozole

Sponsor:

UCLA

Code:

NCT06143631

Conditions

Leiomyoma, Uterine

Leiomyoma

Fibroid

Fibroid Uterus

Eligibility Criteria

Sex: Female

Age: 21 - 53

Healthy Volunteers: Accepted

Interventions

Letrozole 2.5mg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-07-22.